Position in KOD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,791,720
+$2,346,999 QoQ
Shares Held
99,468
+92.5% QoQ
Ownership
0.159%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in KOD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026TWO SIGMA INVESTMENTS, LP holds $5,506,832,621 across 316 Biotechnology names. KOD ranks #117 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,992,577 | $659,283,951 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
812,236 | $627,566,023 | |
| 3 | MRNA |
Moderna, Inc.
|
9,086,404 | $461,589,323 | |
| 4 | IONS |
Ionis Pharmaceuticals Inc
|
5,857,629 | $439,849,361 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
3,120,631 | $231,738,058 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
378,146 | $168,857,314 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
1,558,807 | $151,593,980 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
4,432,142 | $144,221,900 |
All Filings in KOD
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,791,720 | 99,468 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,444,721 | 51,671 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,263,332 | 138,261 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $199,170 | 53,397 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $299,725 | 106,664 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $491,589 | 49,406 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $103,003 | 39,465 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $292,365 | 124,411 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $364,817 | 69,357 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,012,620 | 333,099 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $241,731 | 134,295 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $598,050 | 86,674 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $615,139 | 99,216 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,259,923 | 175,967 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,000,488 | 387,660 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,811,627 | 237,124 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $7,639,519 | 989,575 | Shares | Sole | 2022-05-16 | |
| 2021-09-30 | $13,326,727 | 138,849 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $23,062,791 | 247,987 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $7,449,609 | 65,699 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $793,314 | 5,400 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,359,639 | 22,963 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $4,576,766 | 84,567 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $4,426,178 | 92,792 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||